Results 281 to 290 of about 5,096,258 (344)
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Nutrition and Quality of Life for Patients with Chronic Disease. [PDF]
Patelarou E, Giakoumidakis K.
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Hospitalizations and inpatient resource consumption of patients suffering from chronic disease - Past trend and forecast for Switzerland. [PDF]
Bukanova-Berend D +2 more
europepmc +1 more source
Continuity of Chronic Disease Care in Gaza: a Commentary on Health System Collapse and Humanitarian Imperatives. [PDF]
Katchhi MS, Ming LC.
europepmc +1 more source
The Delaware Food Farmacy: Integrating Medically Tailored Groceries and Community Health Workers into Chronic Disease Management. [PDF]
Axe M +3 more
europepmc +1 more source

